A prospective study to assess the role of oral Avanafil and intracavernosal injection of Alprostadil in evaluating patients with low Erection Hardness Score. - NI

I0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年8月21日

试验速览

暂无简介。

•All patients presenting to our OPD with ED of more than 1 month, Irrespective of marital status, comorbidities shall be further evaluated with International Index of Erectile Function (IIEF-5) questionnaire and for all relevant medical and sexual history.
•Only patients with EHS 1 or 2 based on history will be included in the study

•1. Tried PDE5 inhibitors in the past and had discontinued either due to significant side-effects, or had known hypersensitivity to PDE5 inhibitors;
•2. Patients with history of primary hypoactive sexual desire, hypogonadism(serum total testosterone levels less than 300ng/dL)
•3. spinal cord injury,
•4. pelvic surgery and radical prostatectomy;
•5. History of or predisposition to priapism; presence of penile anatomical abnormalities; and use of penile implants.
•6. Penile surgery other than circumcision.
•7. EHS 0 or EHS 3,4.

发起方